Instil Bio, Inc. Operating Lease Liability
Instil Bio, Inc. (TIL) had Operating Lease Liability of $2.23 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability $2.23M.
- 2025-09-30: Operating Lease, Liability $305.00K.
- 2025-06-30: Operating Lease, Liability $462.00K.
- 2025-03-31: Operating Lease, Liability $2.44M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $2.23M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $305.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $462.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.44M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.70M 10-K · filed 2025-03-04 |
| 2024-09-30 | $3.17M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.69M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $4.13M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $4.63M 10-K · filed 2024-03-21 |
| 2023-09-30 | $5.08M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $5.58M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $6.29M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.55M 10-K · filed 2023-03-31 |
| 2022-09-30 | $7.91M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $8.00M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $8.44M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |